A new report says the Trump administration’s disruptions to a global AIDS relief program have forced organizations to close ...

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has ...

HIV treatment has progressed significantly since the 1980s. ART enables viral suppression and prevents transmission, but HIV ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced new clinical and real-world data highlighting its integrase strand transfer ...

Researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology (FMP) have mapped how the influenza A virus rewires infected human cells in unprecedented ...

This important study provides a mechanistic view of how antibody affinity maturation can reshape encounter-state landscapes and association pathways, with implications for understanding HIV antibody ...

A UCSF study finds controlling HIV is not enough when trauma, addiction, mental illness and housing instability continue to threaten patients' lives.

A psychologist, he wrote during the AIDS crisis about survivor’s guilt and depression in his H.I.V.-negative patients.

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

Around one in three people worldwide have been infected with a microscopic parasite called Toxoplasma gondii – or simply ...

And while the regional response is more robust than it was during the largest outbreak, in 2014-2016, the U.S. has now ...